CryoLife, Inc. (CRY) News
Filter CRY News Items
CRY News Results
|Loading, please wait...|
CRY News Highlights
- For CRY, its 30 day story count is now at 9.
- Over the past 22 days, CRY's stories per day has been in a clear downtrend, falling by about 0.50 per 4 days.
- The most mentioned tickers in articles about CRY are NEO.
Latest CRY News From Around the Web
Below are the latest news stories about Cryolife Inc that investors may wish to consider to help them evaluate CRY as an investment opportunity.
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony "Tony" Semedo to its Board of Directors effective October 1, 2021.
Artificial Tissue Heart Valve Market Introducing New Industry Dynamics through Swot Analysis 2021|Edwards Lifesciences, Medtronic, Abbott, Livanova, Boston Scientific, Cryolife
Artificial Tissue Heart Valve Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors.
CryoLife found using ticker (CRY) now have 4 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 39 and 30.75 with a mean TP of 34.19. With the stocks previous close at 26.45 this indicates there is a potential upside of 29.3%. The 50 day moving average now sits at 26.11 and the 200 moving average now moves to 26.33. The company has a market capitalisation of $1,013m. Company Website: /> [stock_market_widget type="chart" symbol="CRY" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] CryoLife manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for...
Global Transcatheter Heart Valve Replacement Devices Market Report 2021 Featuring Edwards Lifesciences, Medtronic, Livanova, Abbott, Boston Scientific, CryoLife
Dublin, Sept. 03, 2021 (GLOBE NEWSWIRE) -- The "Transcatheter Heart Valve Replacement Devices - Market Insights, Competitive Landscape and Market Forecast - 2026" drug pipelines has been added to ResearchAndMarkets.com''s offering. The Transcatheter Heart Valve Replacement Devices (THVR) market report provides an overview of THVR, applications of THVR as well as its PEST Analysis. Additionally, the report provides insight on the THVR market share of the individual THVR, current and forecasted THVR market size from 2018 to 2026, segmented by seven major markets. The report also covers the market drivers, market barriers and unmet needs to curate the best of opportunities and assesses underlying potential of the market. Transcatheter Heart Valve Replacement Devices (THVR) - Competitive An...
Organ and Tissue Transplantation Market Skyrocketing US$ 25 Bn by 2021-28 | CryoLife, Folio Biosciences, Arthrex, Abbvie, Zimmer Biomet, Medtronic, Novartis AG, Stryker, BiolifeSolutions, Teva, Veloxis
Global Tissue and Organ Transplantation Market to Surpass US$ 25.6 Billion at CAGR of +9% by 2028. A transplant is an organ, tissue or a group of cells removed from one person (the donor) and surgically transplanted into another person (the
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021. The Company's virtual fireside chat is scheduled to begin at 12:30 p.m. ET.
Endovascular Aneurysm Repair Devices Market Useful Survey Report Predicts Astounding Growth by 2027, Industry Players - Getinge Group, Endologix, Cardiatis, CryoLife (Jotec GmbH), BiFlow Medical, EndoSpan, Lemaitre Vascular
The Endovascular Aneurysm Repair Devices Market is expected to grow at a CAGR of 6.1 % and is poised to reach $XX Billion by 2027 as compared to $XX Billion in 2020 Recent research from Decisive Markets Insights looks at the
Global $167 BN Regenerative Medicine Markets, 2021-2029 with Amgen, Novartis, Medtronic., Stryker, CryoLife, Integra LifeSciences, 3M Co, AbbVie, Zimmer Biomet Dominating
Dublin, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market Outlook 2029" report has been added to ResearchAndMarkets.com''s offering.
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences.
CRY earnings call for the period ending June 30, 2021.